文献速递临床试验与 GCP流行病学与生物统计

提升老年人疫苗临床试验参与度:挑战与策略

Enhancing vaccine clinical trials participation among elderly: challenges and strategies.
PubMed 文献 · Trials · 2025-02-03

本文聚焦老年人在临床试验中历史性参与不足的现状,指出近期纳入超过3万名老年参与者的大型试验已证明大规模试验的可行性,并讨论多病共存、衰弱及认知障碍者知情同意等挑战,分享促进入组与保留的创新策略。

要点

  • 老年人临床试验参与率呈上升趋势,近期大型试验已纳入超过3万名老年参与者。
  • 多病共存、衰弱及认知障碍者的知情同意是老年试验的特殊挑战。
  • 定期联系、亲友参与、便利出行、数字工具及社区组织合作是有效策略。

核心结论

  • 通过考虑老年人群独特需求与局限的创新策略,可实现成功的临床试验参与,从而为不断增长的老年人群带来更有效的治疗与干预。

研究设计与样本

  • 本文为针对老年人临床试验参与挑战与策略的论述,分享作者在老年受试者入组与保留方面的经验与成功案例。

主要发现

  • 近期纳入超过3万名老年参与者的大型试验已证明在该特定人群中开展大规模临床试验的可行性。
  • 多病共存、衰弱及认知障碍者知情同意等独特挑战需要持续审慎评估与灵活性。

临床怎么用

  • 作者分享的成功策略包括定期联系、家人朋友参与、使出行更容易或非必需、使用数字工具以及与社区组织建立关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the fastest growing demographic worldwide, the elderly population is projected to reach nearly 1 billion by 2030 and double the 2022 number by 2050. Despite being the largest consumers of medications, they have been historically underrepresented in clinical trials. However, we are witnessing a promising shift as their participation in trials is on the rise. In fact, recent megatrials enrolling more than 30,000 elderly participants demonstrated the feasibility of large-scale clinical trials involving this very specific population. However, unique challenges, including multi-morbidities, frailty, and ethically sound informed consent in those with cognitive deficits, require continuous careful reassessments and flexibility. Creative and tailored strategies are of paramount importance to bolster elderly trial participation. This paper highlights challenges and shares our experiences on novel methods and success stories associated with the enrollment and retention of elderly individuals in clinical trials. Successful tactics to balance the burden of clinical trial participation with its benefits encompass regular contact, family and friends' engagement, making travel easier or unnecessary, use of digital tools, and building relationships with community organizations. Through innovative strategies that consider the unique needs and limitations of this population, we can achieve successful participation in clinical trials. This will lead to more effective treatments and interventions for our growing elderly population.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gillard P, Nakhle S, Brimhall D, et al. Enhancing vaccine clinical trials participation among elderly: challenges and strategies. Trials. 2025. PMID: 39901271. doi:10.1186/s13063-025-08754-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。